CRYOPORT, INC. Unrealized Gain (Loss) on Derivatives
CRYOPORT, INC. (CYRX) reported Unrealized Gain (Loss) on Derivatives of $0 for the 12-month period ending 2015-03-31, per its 10-K filed 2015-05-19.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnDerivatives · last filed 2015-05-19
- CRYOPORT, INC. unrealized gain (loss) on derivatives for the quarter ending 2015-03-31 was $0.00, a 100.00% decline year-over-year.
- CRYOPORT, INC. unrealized gain (loss) on derivatives for the quarter ending 2014-12-31 was $0.00, a 100.00% decline year-over-year.
- CRYOPORT, INC. unrealized gain (loss) on derivatives for the quarter ending 2014-09-30 was $0.00, a 100.00% decline year-over-year.
- CRYOPORT, INC. unrealized gain (loss) on derivatives for the quarter ending 2014-06-30 was $0.00, a 100.00% decline year-over-year.
- CRYOPORT, INC. unrealized gain (loss) on derivatives for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- CRYOPORT, INC. unrealized gain (loss) on derivatives for fiscal 2014 was $20.85K, a 26.46% increase from fiscal 2013.
- CRYOPORT, INC. unrealized gain (loss) on derivatives for fiscal 2013 was $16.49K, a 86.17% decline from fiscal 2012.
- CRYOPORT, INC. unrealized gain (loss) on derivatives for fiscal 2012 was $119.16K, a 140.30% increase from fiscal 2011.
| Period end | Unrealized Gain (Loss) on Derivatives 3 month | Unrealized Gain (Loss) on Derivatives 6 month | Unrealized Gain (Loss) on Derivatives 9 month | Unrealized Gain (Loss) on Derivatives 12 month |
|---|---|---|---|---|
| 2015-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-05-19 | $0.00 derived: sum of 2 quarters · filed 2015-05-19 | $0.00 derived: sum of 3 quarters · filed 2015-05-19 | $0.00 10-K · filed 2015-05-19 |
| 2014-12-31 | $0.00 10-Q · filed 2015-02-05 | $0.00 derived: sum of 2 quarters · filed 2015-02-05 | $0.00 10-Q · filed 2015-02-05 | $3.00 derived: sum of 4 quarters · filed 2015-05-19 |
| 2014-09-30 | $0.00 10-Q · filed 2014-11-12 | $0.00 10-Q · filed 2014-11-12 | $3.00 derived: sum of 3 quarters · filed 2015-05-19 | $1.20K derived: sum of 4 quarters · filed 2015-05-19 |
| 2014-06-30 | $0.00 10-Q · filed 2014-07-31 | $3.00 derived: sum of 2 quarters · filed 2015-05-19 | $1.20K derived: sum of 3 quarters · filed 2015-05-19 | $2.09K derived: sum of 4 quarters · filed 2015-05-19 |
| 2014-03-31 | $3.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-05-19 | $1.20K derived: sum of 2 quarters · filed 2015-05-19 | $2.09K derived: sum of 3 quarters · filed 2015-05-19 | $20.85K 10-K · filed 2015-05-19 |
| 2013-12-31 | $1.20K 10-Q · filed 2015-02-05 | $2.09K derived: sum of 2 quarters · filed 2015-02-05 | $20.84K 10-Q · filed 2015-02-05 | $9.62K derived: sum of 4 quarters · filed 2015-02-05 |
| 2013-09-30 | $892.00 10-Q · filed 2014-11-12 | $19.65K 10-Q · filed 2014-11-12 | $8.42K derived: sum of 3 quarters · filed 2014-11-12 | $2.31K derived: sum of 4 quarters · filed 2014-11-12 |
| 2013-06-30 | $18.76K 10-Q · filed 2014-07-31 | $7.53K derived: sum of 2 quarters · filed 2014-07-31 | $1.42K derived: sum of 3 quarters · filed 2014-07-31 | $15.91K derived: sum of 4 quarters · filed 2014-07-31 |
| 2013-03-31 | -$11.23K derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-25 | -$17.34K derived: sum of 2 quarters · filed 2014-06-25 | -$2.85K derived: sum of 3 quarters · filed 2014-06-25 | $16.49K 10-K · filed 2014-06-25 |
| 2012-12-31 | -$6.11K 10-Q · filed 2014-02-13 | $8.38K derived: sum of 2 quarters · filed 2014-02-13 | $27.71K 10-Q · filed 2014-02-13 | $37.72K derived: sum of 4 quarters · filed 2014-02-13 |
| 2012-09-30 | $14.49K 10-Q · filed 2013-11-18 | $33.82K 10-Q · filed 2013-11-18 | $43.83K derived: sum of 3 quarters · filed 2013-11-18 | $104.02K derived: sum of 4 quarters · filed 2013-11-18 |
| 2012-06-30 | $19.34K 10-Q · filed 2013-08-14 | $29.34K derived: sum of 2 quarters · filed 2013-08-14 | $89.53K derived: sum of 3 quarters · filed 2013-08-14 | $104.22K derived: sum of 4 quarters · filed 2013-08-14 |
| 2012-03-31 | $10.01K derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-25 | $70.19K derived: sum of 2 quarters · filed 2013-06-25 | $84.88K derived: sum of 3 quarters · filed 2013-06-25 | $119.16K 10-K · filed 2013-06-25 |
| 2011-12-31 | $60.19K 10-Q · filed 2013-02-14 | $74.87K derived: sum of 2 quarters · filed 2013-02-14 | $109.15K 10-Q · filed 2013-02-14 | -$118.12K derived: sum of 4 quarters · filed 2013-02-14 |
| 2011-09-30 | $14.69K 10-Q · filed 2012-11-09 | $48.97K 10-Q · filed 2012-11-09 | -$178.30K derived: sum of 3 quarters · filed 2012-11-09 | -$144.31K derived: sum of 4 quarters · filed 2012-11-09 |
| 2011-06-30 | $34.28K 10-Q · filed 2012-08-14 | -$192.99K derived: sum of 2 quarters · filed 2012-08-14 | -$159.00K derived: sum of 3 quarters · filed 2012-08-14 | -$32.66K derived: sum of 4 quarters · filed 2012-08-14 |
| 2011-03-31 | -$227.27K derived: 10-K 12 month − 10-Q 9 month · filed 2012-06-27 | -$193.28K derived: sum of 2 quarters · filed 2012-06-27 | -$66.94K derived: sum of 3 quarters · filed 2012-06-27 | $49.59K 10-K · filed 2012-06-27 |
| 2010-12-31 | $33.99K 10-Q · filed 2012-02-21 | $160.33K derived: sum of 2 quarters · filed 2012-02-21 | $276.86K 10-Q · filed 2012-02-21 | |
| 2010-09-30 | $126.34K 10-Q · filed 2011-11-14 | $242.87K 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | $116.53K 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |